tiprankstipranks
Shandong Weigao Group Medical Polymer Co Ltd Class H (DE:UK2)
FRANKFURT:UK2
Germany Market
UK2
Shandong Weigao Group Medical Polymer Co
RESEARCH TOOLSreports

Shandong Weigao Group Medical Polymer Co (UK2) Ratios

1 Followers

Shandong Weigao Group Medical Polymer Co Ratios

DE:UK2's free cash flow for Q2 2026 was ¥0.46. For the 2026 fiscal year, DE:UK2's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.09 3.78 3.20 2.46 3.08
Quick Ratio
 2.70 3.32 2.78 2.13 2.69
Cash Ratio
 1.20 1.64 1.28 0.92 1.16
Solvency Ratio
 0.25 0.25 0.31 0.30 0.37
Operating Cash Flow Ratio
 0.43 0.47 0.46 0.37 0.37
Short-Term Operating Cash Flow Coverage
 1.28 5.90 2.32 1.10 2.30
Net Current Asset Value
¥ 10.63B¥ 10.44B¥ 10.02B¥ 8.96B¥ 8.54B
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.17 0.12 0.12 0.14
Debt-to-Equity Ratio
 0.20 0.25 0.18 0.19 0.21
Debt-to-Capital Ratio
 0.17 0.20 0.15 0.16 0.17
Long-Term Debt-to-Capital Ratio
 0.09 0.15 0.11 0.06 0.14
Financial Leverage Ratio
 1.46 1.50 1.46 1.50 1.53
Debt Service Coverage Ratio
 0.97 3.57 1.89 1.15 3.42
Interest Coverage Ratio
 6.49 6.82 9.56 7.48 15.28
Debt to Market Cap
 0.40 0.23 0.21 0.13 0.09
Interest Debt Per Share
 1.15 1.37 0.98 0.98 1.04
Net Debt to EBITDA
 -1.04 -1.09 -1.14 -0.79 -0.54
Profitability Margins
Gross Profit Margin
45.56%47.26%50.28%50.21%53.64%
EBIT Margin
13.22%13.79%17.37%19.97%26.27%
EBITDA Margin
20.25%20.56%24.01%26.86%32.16%
Operating Profit Margin
12.13%12.69%18.23%15.44%21.47%
Pretax Profit Margin
13.51%15.17%19.51%17.91%24.86%
Net Profit Margin
10.13%12.04%15.79%15.13%20.30%
Continuous Operations Profit Margin
10.83%12.78%16.53%15.58%21.66%
Net Income Per EBT
74.97%79.36%80.93%84.50%81.64%
EBT Per EBIT
111.42%119.58%107.02%115.99%115.77%
Return on Assets (ROA)
3.85%4.47%5.95%5.95%8.33%
Return on Equity (ROE)
5.64%6.68%8.70%8.92%12.76%
Return on Capital Employed (ROCE)
5.63%5.55%8.32%7.83%10.73%
Return on Invested Capital (ROIC)
4.20%4.60%6.75%6.20%8.96%
Return on Tangible Assets
4.42%5.15%6.98%7.00%9.93%
Earnings Yield
11.48%7.88%10.59%6.57%5.42%
Efficiency Ratios
Receivables Turnover
 1.58 1.62 1.76 2.22 2.37
Payables Turnover
 5.25 5.79 1.52 1.52 3.61
Inventory Turnover
 2.89 2.81 2.57 2.64 2.81
Fixed Asset Turnover
 1.80 1.78 1.85 1.89 1.86
Asset Turnover
 0.38 0.37 0.38 0.39 0.41
Working Capital Turnover Ratio
 0.94 0.94 1.07 1.13 1.16
Cash Conversion Cycle
 288.18 292.86 108.88 63.34 182.59
Days of Sales Outstanding
 231.38 225.86 207.93 164.44 153.71
Days of Inventory Outstanding
 126.35 130.05 141.84 138.29 129.90
Days of Payables Outstanding
 69.55 63.05 240.89 239.39 101.02
Operating Cycle
 357.73 355.91 349.77 302.72 283.61
Cash Flow Ratios
Operating Cash Flow Per Share
 0.62 0.56 0.61 0.62 0.49
Free Cash Flow Per Share
 0.24 0.38 0.48 0.46 0.24
CapEx Per Share
 0.38 0.18 0.13 0.15 0.25
Free Cash Flow to Operating Cash Flow
 0.38 0.67 0.79 0.75 0.50
Dividend Paid and CapEx Coverage Ratio
 1.62 1.37 1.90 1.97 1.19
Capital Expenditure Coverage Ratio
 1.62 3.06 4.68 4.08 1.98
Operating Cash Flow Coverage Ratio
 0.57 0.43 0.67 0.67 0.49
Operating Cash Flow to Sales Ratio
 0.21 0.19 0.21 0.21 0.16
Free Cash Flow Yield
9.20%8.40%11.23%6.94%2.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.78 12.88 9.45 15.22 18.45
Price-to-Sales (P/S) Ratio
 0.87 1.53 1.49 2.30 3.74
Price-to-Book (P/B) Ratio
 0.49 0.85 0.82 1.36 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
 10.86 11.91 8.91 14.42 46.44
Price-to-Operating Cash Flow Ratio
 4.25 8.02 7.00 10.89 23.03
Price-to-Earnings Growth (PEG) Ratio
 -0.31 -0.54 2.08 -0.55 0.94
Price-to-Fair Value
 0.49 0.85 0.82 1.36 2.35
Enterprise Value Multiple
 3.25 6.34 5.07 7.78 11.10
Enterprise Value
 8.88B 17.46B 15.94B 27.65B 48.63B
EV to EBITDA
 3.25 6.34 5.07 7.78 11.10
EV to Sales
 0.66 1.30 1.22 2.09 3.57
EV to Free Cash Flow
 8.24 10.17 7.27 13.08 44.28
EV to Operating Cash Flow
 3.17 6.85 5.71 9.88 21.96
Tangible Book Value Per Share
 4.77 4.65 4.45 4.16 4.01
Shareholders’ Equity Per Share
 5.39 5.31 5.23 4.93 4.81
Tax and Other Ratios
Effective Tax Rate
 0.20 0.16 0.15 0.13 0.13
Revenue Per Share
 2.98 2.95 2.88 2.91 3.02
Net Income Per Share
 0.30 0.36 0.46 0.44 0.61
Tax Burden
 0.75 0.79 0.81 0.84 0.82
Interest Burden
 1.02 1.10 1.12 0.90 0.95
Research & Development to Revenue
 0.06 0.06 0.05 0.06 0.04
SG&A to Revenue
 0.28 0.29 0.28 0.09 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 2.05 1.26 1.09 1.18 0.67
Currency in CNY